Christopher Robert Sudfeld, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tanzania | 74 | 2024 | 1346 | 4.930 |
Why?
|
Micronutrients | 18 | 2022 | 375 | 4.210 |
Why?
|
Child Development | 30 | 2024 | 2223 | 4.190 |
Why?
|
Dietary Supplements | 41 | 2024 | 3297 | 3.640 |
Why?
|
HIV Infections | 39 | 2023 | 16718 | 2.780 |
Why?
|
Premature Birth | 15 | 2024 | 1721 | 2.650 |
Why?
|
Cholecalciferol | 5 | 2022 | 537 | 2.090 |
Why?
|
Vitamin D Deficiency | 9 | 2022 | 1343 | 1.980 |
Why?
|
Infant Mortality | 10 | 2023 | 754 | 1.600 |
Why?
|
Growth Disorders | 13 | 2024 | 645 | 1.510 |
Why?
|
Anemia, Iron-Deficiency | 8 | 2022 | 365 | 1.500 |
Why?
|
Tuberculosis, Pulmonary | 5 | 2020 | 810 | 1.460 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 3 | 2021 | 159 | 1.380 |
Why?
|
Nutritional Status | 12 | 2023 | 1609 | 1.370 |
Why?
|
Malnutrition | 9 | 2024 | 625 | 1.350 |
Why?
|
Vitamins | 15 | 2022 | 1622 | 1.320 |
Why?
|
Maternal Nutritional Physiological Phenomena | 4 | 2020 | 378 | 1.310 |
Why?
|
Pregnancy | 57 | 2024 | 29144 | 1.230 |
Why?
|
Rural Population | 19 | 2022 | 2210 | 1.230 |
Why?
|
Infant, Low Birth Weight | 6 | 2023 | 850 | 1.220 |
Why?
|
Child Nutritional Physiological Phenomena | 5 | 2023 | 303 | 1.210 |
Why?
|
Infant | 68 | 2024 | 35136 | 1.210 |
Why?
|
Motor Skills | 4 | 2019 | 522 | 1.190 |
Why?
|
Vitamin D | 12 | 2022 | 3223 | 1.170 |
Why?
|
Vitamin A | 10 | 2022 | 615 | 1.170 |
Why?
|
Anti-Retroviral Agents | 5 | 2019 | 1715 | 1.160 |
Why?
|
Adolescent Development | 2 | 2021 | 278 | 1.130 |
Why?
|
Folic Acid | 8 | 2022 | 1300 | 1.130 |
Why?
|
Pregnancy Complications | 5 | 2023 | 2861 | 1.110 |
Why?
|
Stillbirth | 6 | 2023 | 346 | 1.050 |
Why?
|
Mothers | 13 | 2023 | 2165 | 1.040 |
Why?
|
Developing Countries | 16 | 2024 | 2815 | 1.020 |
Why?
|
Poverty | 7 | 2021 | 2660 | 1.010 |
Why?
|
Birth Weight | 10 | 2023 | 2069 | 0.970 |
Why?
|
Infant, Newborn | 46 | 2024 | 25625 | 0.940 |
Why?
|
Iron | 10 | 2023 | 1774 | 0.940 |
Why?
|
Pregnancy Complications, Infectious | 7 | 2022 | 2026 | 0.930 |
Why?
|
Thinness | 7 | 2023 | 480 | 0.930 |
Why?
|
Child Nutrition Disorders | 2 | 2021 | 149 | 0.890 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2022 | 56 | 0.880 |
Why?
|
Cognition | 10 | 2022 | 6770 | 0.870 |
Why?
|
HIV Wasting Syndrome | 2 | 2013 | 97 | 0.860 |
Why?
|
Child, Preschool | 53 | 2024 | 41006 | 0.860 |
Why?
|
Antiretroviral Therapy, Highly Active | 8 | 2020 | 1873 | 0.860 |
Why?
|
Depression | 10 | 2023 | 7766 | 0.820 |
Why?
|
Zinc | 7 | 2024 | 684 | 0.810 |
Why?
|
Wasting Syndrome | 3 | 2021 | 101 | 0.810 |
Why?
|
Measles Vaccine | 2 | 2013 | 76 | 0.800 |
Why?
|
Pregnancy Outcome | 8 | 2023 | 2795 | 0.790 |
Why?
|
Intelligence | 3 | 2021 | 920 | 0.780 |
Why?
|
CD4 Lymphocyte Count | 9 | 2022 | 2559 | 0.780 |
Why?
|
Milk, Human | 4 | 2023 | 490 | 0.760 |
Why?
|
Pregnant Women | 5 | 2023 | 568 | 0.760 |
Why?
|
Anemia | 9 | 2023 | 1506 | 0.750 |
Why?
|
Prenatal Care | 4 | 2023 | 1092 | 0.740 |
Why?
|
Female | 123 | 2024 | 380194 | 0.740 |
Why?
|
Infant, Small for Gestational Age | 7 | 2023 | 440 | 0.740 |
Why?
|
Breast Feeding | 9 | 2023 | 1338 | 0.730 |
Why?
|
Double-Blind Method | 18 | 2023 | 12026 | 0.730 |
Why?
|
Opportunistic Infections | 2 | 2013 | 389 | 0.700 |
Why?
|
Hypercalcemia | 1 | 2022 | 409 | 0.690 |
Why?
|
Income | 4 | 2021 | 1913 | 0.680 |
Why?
|
Unemployment | 2 | 2021 | 214 | 0.670 |
Why?
|
Education, Nonprofessional | 1 | 2018 | 34 | 0.640 |
Why?
|
Measles | 2 | 2010 | 168 | 0.620 |
Why?
|
Lactation | 4 | 2022 | 412 | 0.620 |
Why?
|
Child | 53 | 2024 | 77709 | 0.610 |
Why?
|
Humans | 154 | 2024 | 744343 | 0.610 |
Why?
|
Punishment | 1 | 2018 | 98 | 0.610 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 571 | 0.570 |
Why?
|
World Health Organization | 2 | 2019 | 1318 | 0.550 |
Why?
|
Alanine Transaminase | 1 | 2019 | 592 | 0.550 |
Why?
|
Health Status | 6 | 2020 | 4034 | 0.550 |
Why?
|
Anti-HIV Agents | 6 | 2023 | 4256 | 0.540 |
Why?
|
Diarrhea | 7 | 2024 | 1348 | 0.540 |
Why?
|
Nutrition Policy | 2 | 2019 | 488 | 0.530 |
Why?
|
Executive Function | 2 | 2021 | 1364 | 0.510 |
Why?
|
Prospective Studies | 28 | 2024 | 53288 | 0.510 |
Why?
|
Tuberculosis | 4 | 2022 | 1912 | 0.490 |
Why?
|
Anthropometry | 5 | 2023 | 1350 | 0.480 |
Why?
|
Cross-Sectional Studies | 29 | 2024 | 25043 | 0.480 |
Why?
|
Morbidity | 7 | 2023 | 1769 | 0.480 |
Why?
|
Fetal Development | 1 | 2020 | 767 | 0.480 |
Why?
|
Growth | 2 | 2016 | 376 | 0.470 |
Why?
|
Gestational Age | 3 | 2021 | 3493 | 0.470 |
Why?
|
Aftercare | 4 | 2024 | 866 | 0.460 |
Why?
|
Mental Health | 4 | 2020 | 3019 | 0.460 |
Why?
|
Diet | 7 | 2021 | 7939 | 0.450 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2017 | 657 | 0.450 |
Why?
|
Adolescent | 35 | 2023 | 85781 | 0.440 |
Why?
|
Research | 1 | 2021 | 1999 | 0.440 |
Why?
|
Male | 75 | 2024 | 350118 | 0.420 |
Why?
|
Adult | 56 | 2023 | 214055 | 0.420 |
Why?
|
Vitamin B 12 | 3 | 2020 | 527 | 0.420 |
Why?
|
Herpes Genitalis | 1 | 2013 | 141 | 0.420 |
Why?
|
Herpesvirus 2, Human | 1 | 2013 | 189 | 0.410 |
Why?
|
Antibodies, Viral | 2 | 2013 | 3176 | 0.410 |
Why?
|
Ethiopia | 7 | 2022 | 495 | 0.400 |
Why?
|
Young Adult | 33 | 2022 | 56430 | 0.400 |
Why?
|
Hemoglobins | 7 | 2022 | 1534 | 0.390 |
Why?
|
Vitamin A Deficiency | 4 | 2017 | 101 | 0.390 |
Why?
|
Selenium | 1 | 2014 | 405 | 0.390 |
Why?
|
India | 7 | 2021 | 2197 | 0.380 |
Why?
|
Cohort Studies | 19 | 2024 | 40561 | 0.370 |
Why?
|
Socioeconomic Factors | 14 | 2021 | 7785 | 0.360 |
Why?
|
Serum Albumin | 1 | 2013 | 676 | 0.350 |
Why?
|
Iron, Dietary | 2 | 2023 | 141 | 0.350 |
Why?
|
Patient Compliance | 1 | 2020 | 2684 | 0.350 |
Why?
|
Infectious Disease Transmission, Vertical | 4 | 2022 | 1320 | 0.350 |
Why?
|
Viral Load | 5 | 2023 | 3299 | 0.340 |
Why?
|
Chickens | 2 | 2021 | 865 | 0.330 |
Why?
|
Infant Nutritional Physiological Phenomena | 4 | 2019 | 347 | 0.330 |
Why?
|
Risk Factors | 28 | 2024 | 72290 | 0.330 |
Why?
|
Disease Transmission, Infectious | 1 | 2014 | 547 | 0.320 |
Why?
|
Niger | 3 | 2022 | 39 | 0.320 |
Why?
|
Vaccination | 2 | 2022 | 3278 | 0.310 |
Why?
|
Peer Group | 1 | 2012 | 635 | 0.300 |
Why?
|
Health Promotion | 2 | 2019 | 2205 | 0.300 |
Why?
|
Weight Loss | 2 | 2022 | 2622 | 0.300 |
Why?
|
Patient Discharge | 4 | 2024 | 3313 | 0.290 |
Why?
|
Fungi | 1 | 2009 | 327 | 0.290 |
Why?
|
Brazil | 5 | 2021 | 1270 | 0.290 |
Why?
|
Mycoses | 1 | 2009 | 376 | 0.280 |
Why?
|
Randomized Controlled Trials as Topic | 12 | 2024 | 9959 | 0.280 |
Why?
|
Linear Models | 5 | 2021 | 5952 | 0.280 |
Why?
|
Developmental Disabilities | 3 | 2019 | 1456 | 0.280 |
Why?
|
Prevalence | 14 | 2022 | 15226 | 0.270 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2022 | 489 | 0.270 |
Why?
|
Pakistan | 2 | 2023 | 295 | 0.270 |
Why?
|
RNA, Viral | 1 | 2014 | 2902 | 0.260 |
Why?
|
Incidence | 10 | 2020 | 20947 | 0.250 |
Why?
|
Dysentery | 1 | 2024 | 15 | 0.250 |
Why?
|
Meconium Aspiration Syndrome | 1 | 2024 | 29 | 0.240 |
Why?
|
Body Height | 5 | 2019 | 1577 | 0.240 |
Why?
|
Animal Husbandry | 2 | 2021 | 66 | 0.230 |
Why?
|
Quality Improvement | 1 | 2019 | 3749 | 0.230 |
Why?
|
Pre-Eclampsia | 2 | 2024 | 1200 | 0.230 |
Why?
|
Age Factors | 11 | 2021 | 18370 | 0.230 |
Why?
|
Africa South of the Sahara | 6 | 2023 | 724 | 0.220 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2019 | 2408 | 0.220 |
Why?
|
Placebos | 2 | 2020 | 1676 | 0.210 |
Why?
|
Maternal Age | 4 | 2019 | 802 | 0.210 |
Why?
|
Disease Progression | 3 | 2022 | 13284 | 0.210 |
Why?
|
Anxiety | 1 | 2017 | 4297 | 0.210 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.210 |
Why?
|
Malawi | 3 | 2023 | 282 | 0.210 |
Why?
|
China | 4 | 2021 | 2248 | 0.210 |
Why?
|
Communication | 1 | 2015 | 3749 | 0.200 |
Why?
|
Nutritive Value | 2 | 2021 | 339 | 0.190 |
Why?
|
Clinical Protocols | 2 | 2017 | 1462 | 0.190 |
Why?
|
Treatment Outcome | 11 | 2022 | 63114 | 0.190 |
Why?
|
Health Behavior | 4 | 2020 | 2636 | 0.190 |
Why?
|
Peru | 3 | 2019 | 881 | 0.190 |
Why?
|
Sex Factors | 10 | 2022 | 10397 | 0.190 |
Why?
|
Models, Theoretical | 3 | 2021 | 3589 | 0.190 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1177 | 0.190 |
Why?
|
Infant Nutrition Disorders | 2 | 2018 | 73 | 0.190 |
Why?
|
Education | 2 | 2021 | 543 | 0.190 |
Why?
|
Antidiarrheals | 1 | 2020 | 45 | 0.190 |
Why?
|
Language Development | 2 | 2019 | 187 | 0.190 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2022 | 300 | 0.190 |
Why?
|
Azithromycin | 1 | 2021 | 196 | 0.180 |
Why?
|
Armenia | 1 | 2020 | 17 | 0.180 |
Why?
|
Follow-Up Studies | 12 | 2022 | 39050 | 0.180 |
Why?
|
Educational Status | 2 | 2019 | 2540 | 0.180 |
Why?
|
Growth Hormone | 1 | 2022 | 705 | 0.180 |
Why?
|
BCG Vaccine | 1 | 2022 | 369 | 0.170 |
Why?
|
Eggs | 1 | 2020 | 184 | 0.170 |
Why?
|
Survival Analysis | 3 | 2019 | 10252 | 0.170 |
Why?
|
Maternal Behavior | 1 | 2021 | 311 | 0.170 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 426 | 0.170 |
Why?
|
Immunoglobulins | 1 | 2022 | 881 | 0.170 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12245 | 0.170 |
Why?
|
Urban Population | 4 | 2021 | 2021 | 0.170 |
Why?
|
Hematologic Tests | 1 | 2020 | 240 | 0.170 |
Why?
|
Administration, Oral | 3 | 2021 | 3913 | 0.160 |
Why?
|
Financial Support | 1 | 2019 | 115 | 0.160 |
Why?
|
Intelligence Tests | 1 | 2019 | 505 | 0.160 |
Why?
|
Liberia | 3 | 2024 | 167 | 0.160 |
Why?
|
Child Mortality | 2 | 2011 | 198 | 0.160 |
Why?
|
Drug Administration Schedule | 3 | 2021 | 4933 | 0.160 |
Why?
|
Quality of Life | 1 | 2020 | 12804 | 0.160 |
Why?
|
Vietnam | 1 | 2019 | 408 | 0.160 |
Why?
|
Calcium, Dietary | 2 | 2022 | 526 | 0.160 |
Why?
|
Ferritins | 4 | 2022 | 590 | 0.160 |
Why?
|
Time Factors | 5 | 2021 | 40075 | 0.160 |
Why?
|
Quality-Adjusted Life Years | 3 | 2012 | 1683 | 0.160 |
Why?
|
Mother-Child Relations | 1 | 2021 | 481 | 0.150 |
Why?
|
Botswana | 2 | 2022 | 1040 | 0.150 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2019 | 227 | 0.150 |
Why?
|
Perinatal Care | 1 | 2020 | 227 | 0.150 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2019 | 183 | 0.150 |
Why?
|
House Calls | 1 | 2019 | 160 | 0.150 |
Why?
|
Longitudinal Studies | 5 | 2019 | 13989 | 0.150 |
Why?
|
Proportional Hazards Models | 6 | 2015 | 12354 | 0.150 |
Why?
|
Single-Blind Method | 1 | 2021 | 1590 | 0.150 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2022 | 2015 | 0.140 |
Why?
|
HIV-1 | 1 | 2014 | 6939 | 0.140 |
Why?
|
Psychotherapy, Group | 1 | 2020 | 406 | 0.140 |
Why?
|
Postpartum Period | 2 | 2020 | 1086 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6538 | 0.140 |
Why?
|
Middle Aged | 19 | 2021 | 213383 | 0.140 |
Why?
|
Schools | 2 | 2021 | 1433 | 0.130 |
Why?
|
Calcium | 3 | 2024 | 5756 | 0.130 |
Why?
|
Eating | 2 | 2021 | 1536 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2024 | 1401 | 0.130 |
Why?
|
Body Mass Index | 6 | 2020 | 12720 | 0.130 |
Why?
|
Anti-Bacterial Agents | 4 | 2024 | 7181 | 0.130 |
Why?
|
Communication Disorders | 1 | 2015 | 51 | 0.130 |
Why?
|
Motor Skills Disorders | 1 | 2015 | 90 | 0.130 |
Why?
|
School Health Services | 1 | 2019 | 375 | 0.130 |
Why?
|
HIV | 1 | 2022 | 1604 | 0.130 |
Why?
|
Research Design | 4 | 2019 | 5987 | 0.120 |
Why?
|
Maternal Mortality | 1 | 2017 | 310 | 0.120 |
Why?
|
Program Evaluation | 2 | 2023 | 2488 | 0.120 |
Why?
|
Birth Intervals | 1 | 2014 | 51 | 0.120 |
Why?
|
Body Weight | 2 | 2015 | 4669 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2021 | 857 | 0.120 |
Why?
|
Community Health Services | 1 | 2019 | 650 | 0.120 |
Why?
|
Lipids | 2 | 2022 | 3305 | 0.120 |
Why?
|
Salaries and Fringe Benefits | 1 | 2016 | 264 | 0.120 |
Why?
|
Endemic Diseases | 1 | 2014 | 182 | 0.120 |
Why?
|
Community-Based Participatory Research | 2 | 2019 | 214 | 0.120 |
Why?
|
Communicable Diseases | 1 | 2022 | 880 | 0.110 |
Why?
|
Hepatitis B | 1 | 2019 | 695 | 0.110 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3778 | 0.110 |
Why?
|
Social Environment | 1 | 2018 | 1023 | 0.110 |
Why?
|
Sexual Behavior | 2 | 2019 | 2057 | 0.110 |
Why?
|
Inflammation | 3 | 2022 | 10638 | 0.110 |
Why?
|
Caregivers | 2 | 2022 | 2094 | 0.110 |
Why?
|
Social Class | 1 | 2021 | 1999 | 0.110 |
Why?
|
Antibody Affinity | 1 | 2013 | 254 | 0.110 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 961 | 0.110 |
Why?
|
Maternal Health Services | 1 | 2017 | 455 | 0.100 |
Why?
|
Regression Analysis | 4 | 2016 | 6459 | 0.100 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 401 | 0.100 |
Why?
|
Wounds and Injuries | 3 | 2012 | 2400 | 0.100 |
Why?
|
Goals | 1 | 2017 | 706 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1616 | 0.100 |
Why?
|
Emotions | 3 | 2021 | 2661 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2017 | 847 | 0.100 |
Why?
|
Family Planning Services | 1 | 2014 | 263 | 0.100 |
Why?
|
Pneumonia | 2 | 2013 | 2133 | 0.100 |
Why?
|
Delivery, Obstetric | 1 | 2018 | 906 | 0.100 |
Why?
|
Dehydration | 2 | 2024 | 234 | 0.100 |
Why?
|
Vitamin B Complex | 1 | 2013 | 288 | 0.090 |
Why?
|
Parity | 1 | 2014 | 929 | 0.090 |
Why?
|
Family | 1 | 2021 | 3147 | 0.090 |
Why?
|
Health Surveys | 2 | 2018 | 4037 | 0.090 |
Why?
|
Perinatal Mortality | 1 | 2010 | 105 | 0.090 |
Why?
|
Ghana | 2 | 2022 | 286 | 0.090 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2010 | 370 | 0.090 |
Why?
|
Ascorbic Acid | 1 | 2013 | 651 | 0.090 |
Why?
|
Social Behavior | 1 | 2016 | 1127 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1889 | 0.090 |
Why?
|
Hepatitis C | 1 | 2020 | 1591 | 0.090 |
Why?
|
Infant Food | 2 | 2019 | 141 | 0.090 |
Why?
|
Body Weights and Measures | 2 | 2019 | 211 | 0.090 |
Why?
|
Cost-Benefit Analysis | 4 | 2022 | 5391 | 0.080 |
Why?
|
Adiposity | 1 | 2019 | 1807 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2021 | 2715 | 0.080 |
Why?
|
Students | 1 | 2019 | 1654 | 0.080 |
Why?
|
Immunization Schedule | 1 | 2010 | 221 | 0.080 |
Why?
|
Vitamin E | 1 | 2013 | 869 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2020 | 10943 | 0.080 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4560 | 0.070 |
Why?
|
Administration, Inhalation | 1 | 2009 | 1105 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2971 | 0.070 |
Why?
|
Cost of Illness | 1 | 2016 | 1859 | 0.070 |
Why?
|
Hospitalization | 2 | 2016 | 10262 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 3966 | 0.070 |
Why?
|
Respiratory Function Tests | 1 | 2009 | 1616 | 0.070 |
Why?
|
Disability Evaluation | 1 | 2012 | 1827 | 0.060 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5137 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4644 | 0.060 |
Why?
|
Forced Expiratory Volume | 1 | 2009 | 1743 | 0.060 |
Why?
|
Malaria | 1 | 2014 | 1239 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2019 | 77449 | 0.060 |
Why?
|
Risk Assessment | 3 | 2024 | 23338 | 0.060 |
Why?
|
Interviews as Topic | 2 | 2019 | 2539 | 0.050 |
Why?
|
Learning | 2 | 2021 | 1713 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 204 | 0.050 |
Why?
|
Child Nutrition Sciences | 1 | 2020 | 23 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2015 | 4043 | 0.050 |
Why?
|
Isoniazid | 1 | 2022 | 274 | 0.050 |
Why?
|
Aged | 6 | 2022 | 163280 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6600 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2009 | 1855 | 0.050 |
Why?
|
Diarrhea, Infantile | 1 | 2020 | 109 | 0.050 |
Why?
|
Acute Disease | 2 | 2021 | 7149 | 0.050 |
Why?
|
Length of Stay | 1 | 2013 | 6309 | 0.050 |
Why?
|
Cause of Death | 1 | 2010 | 3584 | 0.040 |
Why?
|
MEDLINE | 1 | 2019 | 125 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
Orosomucoid | 1 | 2018 | 45 | 0.040 |
Why?
|
Edema | 1 | 2023 | 789 | 0.040 |
Why?
|
Spouses | 1 | 2021 | 286 | 0.040 |
Why?
|
Exercise | 3 | 2019 | 5615 | 0.040 |
Why?
|
Weight Gain | 2 | 2019 | 2292 | 0.040 |
Why?
|
Food, Fortified | 1 | 2019 | 191 | 0.040 |
Why?
|
Arm | 1 | 2021 | 589 | 0.040 |
Why?
|
Overweight | 2 | 2019 | 2371 | 0.040 |
Why?
|
Nutritional Sciences | 1 | 2019 | 137 | 0.040 |
Why?
|
Colombia | 1 | 2019 | 258 | 0.040 |
Why?
|
Pregnancy in Adolescence | 1 | 2019 | 158 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57776 | 0.040 |
Why?
|
Diet Surveys | 1 | 2021 | 1173 | 0.040 |
Why?
|
Vomiting | 1 | 2020 | 636 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1677 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 424 | 0.040 |
Why?
|
Minerals | 1 | 2017 | 275 | 0.030 |
Why?
|
Trace Elements | 1 | 2017 | 198 | 0.030 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2019 | 546 | 0.030 |
Why?
|
Protoporphyrins | 1 | 2016 | 164 | 0.030 |
Why?
|
Pregnancy Trimester, First | 1 | 2019 | 853 | 0.030 |
Why?
|
Term Birth | 1 | 2016 | 135 | 0.030 |
Why?
|
Child Behavior | 1 | 2021 | 839 | 0.030 |
Why?
|
Economics | 1 | 2016 | 146 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 911 | 0.030 |
Why?
|
Latin America | 1 | 2016 | 381 | 0.030 |
Why?
|
Diet Records | 1 | 2016 | 425 | 0.030 |
Why?
|
Asia | 1 | 2016 | 610 | 0.030 |
Why?
|
Family Characteristics | 1 | 2019 | 1000 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2016 | 296 | 0.030 |
Why?
|
Databases, Factual | 1 | 2009 | 7729 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2023 | 2232 | 0.030 |
Why?
|
Language | 1 | 2024 | 1471 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1320 | 0.030 |
Why?
|
Disabled Children | 1 | 2017 | 247 | 0.030 |
Why?
|
Pregnancy, Multiple | 1 | 2015 | 217 | 0.030 |
Why?
|
Zinc Sulfate | 1 | 2013 | 17 | 0.030 |
Why?
|
Birth Order | 1 | 2014 | 95 | 0.030 |
Why?
|
United States | 2 | 2019 | 69872 | 0.030 |
Why?
|
Placenta | 1 | 2022 | 1698 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2044 | 0.030 |
Why?
|
Violence | 1 | 2019 | 909 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2017 | 651 | 0.030 |
Why?
|
Food Supply | 1 | 2019 | 524 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 513 | 0.030 |
Why?
|
Indonesia | 1 | 2012 | 119 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2019 | 875 | 0.030 |
Why?
|
Empirical Research | 1 | 2012 | 120 | 0.030 |
Why?
|
Parent-Child Relations | 1 | 2017 | 747 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 29063 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2019 | 21746 | 0.030 |
Why?
|
Bangladesh | 1 | 2012 | 687 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2021 | 2708 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 19905 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 1572 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3952 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3114 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2063 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2020 | 3188 | 0.020 |
Why?
|
Psychometrics | 1 | 2017 | 3002 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1157 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13408 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9687 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3064 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168757 | 0.010 |
Why?
|
Health Policy | 1 | 2010 | 2661 | 0.010 |
Why?
|